Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.
about
25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future PerspectivesMagnetic resonance-guided regional gene delivery strategy using a tumor stroma-permeable nanocarrier for pancreatic cancerAssessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI.Contrast agents in dynamic contrast-enhanced magnetic resonance imaging.
P2860
Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evaluation of a novel macromol ...... apy in a human melanoma model.
@en
Evaluation of a novel macromol ...... apy in a human melanoma model.
@nl
type
label
Evaluation of a novel macromol ...... apy in a human melanoma model.
@en
Evaluation of a novel macromol ...... apy in a human melanoma model.
@nl
prefLabel
Evaluation of a novel macromol ...... apy in a human melanoma model.
@en
Evaluation of a novel macromol ...... apy in a human melanoma model.
@nl
P2093
P2860
P1433
P1476
Evaluation of a novel macromol ...... apy in a human melanoma model.
@en
P2093
Bundit Chaopathomkul
Clemens C Cyran
David M Shames
Michael F Wendland
Robert C Brasch
Victor Rogut
P2860
P304
P356
10.1016/J.ACRA.2013.07.010
P577
2013-10-01T00:00:00Z